Parathyroid hormone suppression by intravenous calcitriol: Role of phosphate, calcium, race and diabetes

American Journal of the Medical Sciences

Volumn 323, Issue 4, 2002, Pages 210-215

  Kant, K Shashi ^a,c   Cook, E Francis ^b   Duncan, Heather ^a,c   Freyberg, Ron ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Dialysis Clinic Inc   (United States)

Author keywords

Calcitriol; Parathyroid hormone; Suppression

Indexed keywords

CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGE; ARTICLE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEMODIALYSIS PATIENT; HORMONAL REGULATION; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; RACE DIFFERENCE; REGRESSION ANALYSIS; SEX;

EID: 0036080399     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200204000-00008     Document Type: Article

References (27)

1. Renal bone disease in 1990; an unmet challenge for the nephrologist
2. Hyperparathyroidism in the hemodialysis population: A survey of 612 patients
3. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients
4. 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture
5. The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells
6. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat
7. 3 of transcription of the pre-proparathyroid hormone gene
8. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol
9. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro
10. Decreased calciumsensing receptor expression in hyperplastic glands of uremic rats: Role of dietary phosphate
11. Safety and efficacy of long-term treatment of secondary hyperparathyroidism with low dose intravenous calcitriol
12. Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism
13. Comparative effect of oral and intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients
14. Intravenous versus oral calcitriol in renal osteodystrophy: Results of a prospective, pulsed and dose-comparable study
15. Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism
16. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism
17. The effect of long-term intravenous administration on parathyroid function in hemodialysis patients
18. Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: Role of calcium, phosphorus and gender
19. Race is major determinant of secondary hyperparathyroidism in uremic patients
20. Parathyroid and bone response of the diabetic patients to uremia
21. Longitudinal data analysis for discrete and continuous outcomes
22. Longitudinal data analysis using generalized linear models
23. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD
24. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure
25. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol)
26. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog
27. Racial differences in bone mineral density and bone loss among end-stage renal disease patients